1 study found for:    NCT01573780
Show Display Options
Rank Status Study
1 Terminated Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: Smac mimetic TL32711;   Drug: gemcitabine hydrochloride;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: biopsy

Indicates status has not been verified in more than two years